Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OMDA
OMDA logo

OMDA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
23.900
Open
22.850
VWAP
23.10
Vol
2.54M
Mkt Cap
1.37B
Low
22.385
Amount
58.77M
EV/EBITDA(TTM)
--
Total Shares
59.45M
EV
1.15B
EV/OCF(TTM)
50.88
P/S(TTM)
4.65
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
Show More

Events Timeline

(ET)
2026-05-07
16:50:00
Omada Health Reports Q1 Revenue of $78.05M
select
2026-04-17 (ET)
2026-04-17
09:10:00
Omada Health Study Shows GLP-1 Members Achieve Significant Weight Loss
select

News

Fool
5.0
07-02Fool
Omada Health CEO's Share Sale Raises Concerns
  • Insider Selling Activity: Omada Health CEO Sean P. Duffy sold 17,258 shares between June 24 and June 26, 2026, for approximately $342,000, marking the largest single sell transaction by Duffy in the past year, indicating available capacity following prior planned sales.
  • Ownership Percentage Change: Post-transaction, Duffy's direct ownership decreased from 0.6928% to 0.6638%, leaving him with a total of 1,246,262 shares (394,603 direct and 851,659 indirect), reflecting a slight dilution of his control over the company.
  • Market Reaction and Pricing: The shares were sold at a weighted average price of $19.82, while Omada Health closed at $20.89 on June 26, suggesting ongoing market confidence despite the CEO's sale, which may raise investor concerns about leadership commitment.
  • Trading Plan Context: This sale was executed under a 10b5-1 trading plan adopted on March 13, 2026, indicating a pre-established liquidity strategy rather than a discretionary action, yet investors should remain cautious of the potential negative signals from insider selling.
NASDAQ.COM
5.0
07-02NASDAQ.COM
Omada Health CEO Duffy's Stock Sale Raises Concerns
  • Insider Selling: Omada Health's CEO Sean P. Duffy sold 17,258 shares from June 24 to June 26 for $342,000, representing about 1.4% of his direct holdings, raising concerns about the company's outlook among investors.
  • Trading Plan Context: The sale was executed under a 10b5-1 trading plan adopted on March 13, 2026, which, while typically seen as compliant, still raises questions about executive confidence, especially so soon after the IPO.
  • Market Reaction and Forecast: Although Duffy's sale may be viewed as a personal financial decision, analysts note that Omada is expected to see a 25% sales increase this year, contrasting sharply with the CEO's stock sale, potentially undermining investor confidence in the company's future.
  • Investor Caution: With Duffy selling shares while Omada Health is not listed among the top investment picks by The Motley Fool Stock Advisor, this could heighten investor caution regarding the stock, particularly in light of the insider selling.
seekingalpha
9.5
05-08seekingalpha
Omada Health Reports Milestone Q1 2026 Earnings with Strong Growth
  • Significant Revenue Growth: Omada Health reported Q1 2026 revenue of $78 million, a 42% year-over-year increase, surpassing analyst estimates of $74.09 million, indicating strong market performance and growth potential.
  • Membership Milestone: The total membership reached 1,025,000 in Q1, reflecting a 51% year-over-year growth, marking a crucial milestone in expanding the customer base and enhancing market competitiveness.
  • Improved Profitability: The company achieved an adjusted EBITDA of $1 million in Q1, with GAAP net loss narrowing to $3 million, demonstrating positive progress in cost control and profitability, especially during its historically most cost-intensive quarter.
  • Optimistic Outlook: Omada raised its full-year revenue guidance to $322 million to $330 million, with adjusted EBITDA expectations of $14 million to $20 million, reflecting management's confidence in future growth, particularly in promoting GLP-1 prescribing capabilities.
Newsfilter
8.5
04-17Newsfilter
Omada Health Study Shows Significant Weight Loss with GLP-1 Therapy
  • Significant Weight Loss: A study by Omada Health reveals that members in the GLP-1 Care Track lost an average of 6.0% of their body weight, 1.8 times more than the 3.3% loss in the control group, highlighting the program's effectiveness in promoting substantial weight loss.
  • Body Composition Improvements: Participants in the Omada program reduced their body fat percentage by 3.3%, double that of the control group, while increasing muscle mass by nearly three times, demonstrating the program's success in enhancing body composition.
  • Mental Health Benefits: The study also indicated that Omada members reported significant improvements in mental health, physical functioning, and confidence in their weight loss efforts, suggesting that the program addresses overall well-being, not just weight metrics.
  • Long-term Clinical Impact: Omada Health's president emphasized that the success of GLP-1 companion programs should focus on high-quality weight loss, which is crucial for long-term health outcomes and the return on investment potential of GLP-1 treatments.
Newsfilter
9.5
04-16Newsfilter
Omada Health to Release Q1 2026 Results on May 7
  • Earnings Release Schedule: Omada Health will announce its Q1 2026 results on May 7, 2026, after market close, and will host a conference call at 4:30 PM ET the same day to provide detailed insights into its financial performance and future outlook.
  • Conference Call Details: The call will feature a live audio webcast available online, with a replay accessible for approximately 12 months post-call, ensuring that investors who cannot attend live can still access critical information.
  • Company Background: Omada Health focuses on innovating healthcare delivery in the U.S., aiming to improve chronic disease management during the intervals between doctor visits by utilizing a virtual-first model that combines human-led care teams, connected devices, and AI technology to provide personalized support to over two million members.
  • Market Impact Analysis: Omada Health's approach not only addresses gaps in traditional healthcare systems but also enhances its competitive edge in chronic disease management through innovative services like GLP-1 therapy support, which is expected to attract more partnerships with employers and health plans.
seekingalpha
6.0
04-14seekingalpha
Omada Health Receives Market Outperform Rating from Citizens
  • Market Coverage Rating: Citizens initiated coverage on Omada Health (OMDA) with a Market Outperform rating and an $18 price target, highlighting the compelling risk-reward profile of the virtual care provider.
  • Customer Relationship Expansion: Analyst Constantine Davides noted that Omada's market reach has surpassed 2,000 customer relationships, showcasing its diversified platform advantages in weight loss and diabetes, thereby enhancing its competitive position.
  • Valuation Analysis: Since its IPO in 2025, Omada has traded at an average EV/NTM revenue multiple of 3.5x, while currently trading at 1.7x based on Citizens' 2026 revenue estimates, indicating significant undervaluation potential.
  • Optimistic Growth Outlook: Davides projects that OMDA's membership could exceed 1 million in 2025, with revenue and EBITDA CAGR estimates of 16% and 44% over the next four years, suggesting ample runway for sustained double-digit growth in the coming years.
Wall Street analysts forecast OMDA stock price to rise
9 Analyst Rating
Wall Street analysts forecast OMDA stock price to rise
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
17.00
Averages
27.00
High
32.00
Current: 0.000
sliders
Low
17.00
Averages
27.00
High
32.00
Morgan Stanley
Craig Hettenbach
Overweight
maintain
$30
AI Analysis
2026-06-22
Reason
Morgan Stanley
Craig Hettenbach
Price Target
$30
AI Analysis
2026-06-22
maintain
Overweight
Reason
Morgan Stanley analyst Craig Hettenbach says it is "overlooked" that Omada Health (OMDA) is significantly more profitable at their current revenue than where Hinge Health (HNGE) was at similar revenue level three years ago and argues that Omada's margin trajectory relative to Hinge "shows the company is very much on the right track." The firm, which sees "catch up potential" in Omada, reiterates an Overweight rating and $30 price target on the shares.
Goldman Sachs
David Roman
Buy
maintain
$23 -> $26
2026-05-08
Reason
Goldman Sachs
David Roman
Price Target
$23 -> $26
2026-05-08
maintain
Buy
Reason
Goldman Sachs analyst David Roman raised the firm's price target on Omada Health to $26 from $23 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OMDA
Unlock Now

Valuation Metrics

The current forward P/E ratio for Omada Health Inc (OMDA.O) is 769.23, compared to its 5-year average forward P/E of -306.10. For a more detailed relative valuation and DCF analysis to assess Omada Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-306.10
Current PE
769.23
Overvalued PE
569.99
Undervalued PE
-1182.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
125.29
Current EV/EBITDA
-60.84
Overvalued EV/EBITDA
545.02
Undervalued EV/EBITDA
-294.44

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.23
Current PS
3.39
Overvalued PS
4.43
Undervalued PS
2.03

Financials

AI Analysis
Annual
Quarterly

Whales Holding OMDA

B
BIT Capital GmbH
Holding
OMDA
+38.33%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Omada Health Inc (OMDA) stock price today?

The current price of OMDA is 23 USD — it has increased 0.66

What is Omada Health Inc (OMDA)'s business?

Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.

What is the price predicton of OMDA Stock?

Wall Street analysts forecast OMDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMDA is27.00 USD with a low forecast of 17.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Omada Health Inc (OMDA)'s revenue for the last quarter?

Omada Health Inc revenue for the last quarter amounts to 78.05M USD, increased 42.00

What is Omada Health Inc (OMDA)'s earnings per share (EPS) for the last quarter?

Omada Health Inc. EPS for the last quarter amounts to -0.05 USD, decreased -70.59

How many employees does Omada Health Inc (OMDA). have?

Omada Health Inc (OMDA) has 916 emplpoyees as of July 08 2026.

What is Omada Health Inc (OMDA) market cap?

Today OMDA has the market capitalization of 1.37B USD.